Clinical Trials · NCT07879612
Semaglutide for the Treatment of Cannabis Use Disorder
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 40
- Start date
- Jan 2027
- Locations
- See registry
- Primary endpoint
- Cannabis cue-reactivity